H. ESER ÖZTÜRK Et Al. , "Tocilizumab for the treatment of Behçet uveitis that failed interferon alpha and anti-tumor necrosis factor-alpha therapy," 14th IOIS Congress 2017, Lausanne , 2017
ESER ÖZTÜRK, H. Et Al. 2017. Tocilizumab for the treatment of Behçet uveitis that failed interferon alpha and anti-tumor necrosis factor-alpha therapy. 14th IOIS Congress 2017, Lausanne .
ESER ÖZTÜRK, H., ORAY, M., & TUTKUN, N. İ., (2017). Tocilizumab for the treatment of Behçet uveitis that failed interferon alpha and anti-tumor necrosis factor-alpha therapy . 14th IOIS Congress 2017, Lausanne
ESER ÖZTÜRK, Hilal, MERİH ORAY, And NURİYE İLKNUR TUTKUN. "Tocilizumab for the treatment of Behçet uveitis that failed interferon alpha and anti-tumor necrosis factor-alpha therapy," 14th IOIS Congress 2017, Lausanne, 2017
ESER ÖZTÜRK, Hilal E. Et Al. "Tocilizumab for the treatment of Behçet uveitis that failed interferon alpha and anti-tumor necrosis factor-alpha therapy." 14th IOIS Congress 2017, Lausanne , 2017
ESER ÖZTÜRK, H. ORAY, M. And TUTKUN, N. İ. (2017) . "Tocilizumab for the treatment of Behçet uveitis that failed interferon alpha and anti-tumor necrosis factor-alpha therapy." 14th IOIS Congress 2017, Lausanne .
@conferencepaper{conferencepaper, author={Hilal Eser Öztürk Et Al. }, title={Tocilizumab for the treatment of Behçet uveitis that failed interferon alpha and anti-tumor necrosis factor-alpha therapy}, congress name={14th IOIS Congress 2017, Lausanne}, city={}, country={}, year={2017}}